Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (up to  days before treatment initiation)
Within  days of treatment initiation:\r\nHemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L (without transfusion or growth factor support/erythropoietin [EPO] dependency)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  (except as noted) days of planned treatment initiation: Hemoglobin >= . g/dL or >= . mmol/L without transfusion or erythropoietin dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L, performed within  days of treatment initiation, without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment registration: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of study registration
Performed within  business days of treatment initiation with the exception of beta- HCG ( hours), if applicable: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).
Performed within  days of treatment initiation: Hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), should be performed within  days of treatment initiation
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment
Hemoglobin ?  g/dL or ? . mmol/L within  days of treatment initiation without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Performed within  days of treatment initiation: hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Within  days prior to the start of study treatment: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
To be performed within  days of treatment initiation: hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).
Obtained =<  days prior to registration: Hemoglobin > . g/dL or >= . mmol/L without transfusion or (EPO) erythropoietin dependency (within  days of assessment)
Within  days prior to on-study date: Hemoglobin ?  g/dL (or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency within  days
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L\r\n* Patients cannot have received transfusion or erythropoietin (EPO) within  days of the hemoglobin (Hgb) lab test
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Obtained =<  days prior to registration: Hemoglobin >= . g/dL without transfusion or erythropoietin (EPO) dependency (=<  days prior to assessment)
Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of registration
Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of registration)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (within - days of treatment initiation)
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency within  days performed within  days of treatment initiation performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), during screening and on cycle , day 
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin: >=  g/dL or . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Completed within  days of SBRT treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency\r\n(within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin ?  g/dL OR ?  g/dL if anemia due to iBCL, without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), should be performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L with transfusion or erythropoietin (EPO) dependency
REGISTRATION TO TREATMENT (STEP ): Hemoglobin (Hgb) >= . g/dL OR >= . mmol/L without transfusion of erythropoietin (EPO) dependency, within  days prior to first dose of pembrolizumab
REGISTRATION TO TREATMENT (STEP ): Hgb >= . g/dL OR >= . mmol/L without transfusion of EPO dependency, within  days prior to first dose of pembrolizumab
Within  days of treatment initiation: hemoglobin >=  g/dl without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin (Hgb) >  g/dL (without transfusion or erythropoietin [EPO] dependency within  days of assessment)
Hemoglobin >= . g/dL (. mmol/L or  g/L) without transfusion or erythropoietin (EPO) dependency (within  days of assessment) obtained =<  days prior to registration
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (within  days prior to day  of protocol therapy)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), should be performed within  days of treatment initiation, unless otherwise indicated
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) within  days of treatment initiation
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)
Hemoglobin (Hgb) >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment of Hgb), obtained within  days prior to C-AMT PET scan
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin dependency (=<  days prior to registration), obtained =<  days prior to registration
Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)
